Selected research
Industry Research
Pharmaceutical Decommissioning Service Industry Research Report 2026
Market perspective
The global Pharmaceutical Decommissioning Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Pharmaceutical Decommissioning Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pharmaceutical Decommissioning Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pharmaceutical Decommissioning Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pharmaceutical Decommissioning Service include KDC Veolia, RCS Pharma, Technical Safety Services, ISPE, Brilliant Equipment Services, Qualitech Environmental Services, Hughes & Salvidge, Divestiture and Pharmagraph, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Pharmaceutical Decommissioning Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pharmaceutical Decommissioning Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharmaceutical Decommissioning Service Market by Company
KDC Veolia
RCS Pharma
Technical Safety Services
ISPE
Brilliant Equipment Services
Qualitech Environmental Services
Hughes & Salvidge
Divestiture
Pharmagraph
RVA Group
DSM Demolition
KERAMIDA Inc
Downwell Enabling Solutions
Pharmaceutical Decommissioning Service Segment by Type
Equipment Decommissioning Service
Facility Decommissioning Service
Laboratory Decommissioning Service
Others
Pharmaceutical Decommissioning Service Segment by Application
Pharmaceutical Manufacturers
Pharmaceutical CDMO
Pharmaceutical Decommissioning Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Decommissioning Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Decommissioning Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Decommissioning Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pharmaceutical Decommissioning Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Equipment Decommissioning Service
- Facility Decommissioning Service
- Laboratory Decommissioning Service
- Others
Applications
- Pharmaceutical Manufacturers
- Pharmaceutical CDMO
Companies covered
- KDC Veolia
- RCS Pharma
- Technical Safety Services
- ISPE
- Brilliant Equipment Services
- Qualitech Environmental Services
- Hughes & Salvidge
- Divestiture
- Pharmagraph
- RVA Group
- DSM Demolition
- KERAMIDA Inc
- Downwell Enabling Solutions
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pharmaceutical Decommissioning Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Equipment Decommissioning Service
- 2.2.3 Facility Decommissioning Service
- 2.2.4 Laboratory Decommissioning Service
- 2.2.5 Others
- 2.3 Pharmaceutical Decommissioning Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical Manufacturers
- 2.3.3 Pharmaceutical CDMO
- 2.4 Assumptions and Limitations
3 Pharmaceutical Decommissioning Service Breakdown Data by Type
- 3.1 Global Pharmaceutical Decommissioning Service Historic Market Size by Type (2021-2026)
- 3.2 Global Pharmaceutical Decommissioning Service Forecasted Market Size by Type (2027-2032)
4 Pharmaceutical Decommissioning Service Breakdown Data by Application
- 4.1 Global Pharmaceutical Decommissioning Service Historic Market Size by Application (2021-2026)
- 4.2 Global Pharmaceutical Decommissioning Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Pharmaceutical Decommissioning Service Market Perspective (2021-2032)
- 5.2 Global Pharmaceutical Decommissioning Service Growth Trends by Region
- 5.2.1 Global Pharmaceutical Decommissioning Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pharmaceutical Decommissioning Service Historic Market Size by Region (2021-2026)
- 5.2.3 Pharmaceutical Decommissioning Service Forecasted Market Size by Region (2027-2032)
- 5.3 Pharmaceutical Decommissioning Service Market Dynamics
- 5.3.1 Pharmaceutical Decommissioning Service Industry Trends
- 5.3.2 Pharmaceutical Decommissioning Service Market Drivers
- 5.3.3 Pharmaceutical Decommissioning Service Market Challenges
- 5.3.4 Pharmaceutical Decommissioning Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pharmaceutical Decommissioning Service Players by Revenue
- 6.1.1 Global Top Pharmaceutical Decommissioning Service Players by Revenue (2021-2026)
- 6.1.2 Global Pharmaceutical Decommissioning Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Pharmaceutical Decommissioning Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pharmaceutical Decommissioning Service Head Office and Area Served
- 6.4 Global Pharmaceutical Decommissioning Service Players, Product Type & Application
- 6.5 Global Pharmaceutical Decommissioning Service Manufacturers Established Date
- 6.6 Global Pharmaceutical Decommissioning Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pharmaceutical Decommissioning Service Market Size (2021-2032)
- 7.2 North America Pharmaceutical Decommissioning Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pharmaceutical Decommissioning Service Market Size by Country (2021-2026)
- 7.4 North America Pharmaceutical Decommissioning Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pharmaceutical Decommissioning Service Market Size (2021-2032)
- 8.2 Europe Pharmaceutical Decommissioning Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pharmaceutical Decommissioning Service Market Size by Country (2021-2026)
- 8.4 Europe Pharmaceutical Decommissioning Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pharmaceutical Decommissioning Service Market Size (2021-2032)
- 9.2 Asia-Pacific Pharmaceutical Decommissioning Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pharmaceutical Decommissioning Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pharmaceutical Decommissioning Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pharmaceutical Decommissioning Service Market Size (2021-2032)
- 10.2 South America Pharmaceutical Decommissioning Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pharmaceutical Decommissioning Service Market Size by Country (2021-2026)
- 10.4 South America Pharmaceutical Decommissioning Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pharmaceutical Decommissioning Service Market Size (2021-2032)
- 11.2 Middle East & Africa Pharmaceutical Decommissioning Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pharmaceutical Decommissioning Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pharmaceutical Decommissioning Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 KDC Veolia
- 12.1.1 KDC Veolia Company Information
- 12.1.2 KDC Veolia Business Overview
- 12.1.3 KDC Veolia Revenue in Pharmaceutical Decommissioning Service Business (2021-2026)
- 12.1.4 KDC Veolia Pharmaceutical Decommissioning Service Product Portfolio
- 12.1.5 KDC Veolia Recent Developments
- 12.2 RCS Pharma
- 12.2.1 RCS Pharma Company Information
- 12.2.2 RCS Pharma Business Overview
- 12.2.3 RCS Pharma Revenue in Pharmaceutical Decommissioning Service Business (2021-2026)
- 12.2.4 RCS Pharma Pharmaceutical Decommissioning Service Product Portfolio
- 12.2.5 RCS Pharma Recent Developments
- 12.3 Technical Safety Services
- 12.3.1 Technical Safety Services Company Information
- 12.3.2 Technical Safety Services Business Overview
- 12.3.3 Technical Safety Services Revenue in Pharmaceutical Decommissioning Service Business (2021-2026)
- 12.3.4 Technical Safety Services Pharmaceutical Decommissioning Service Product Portfolio
- 12.3.5 Technical Safety Services Recent Developments
- 12.4 ISPE
- 12.4.1 ISPE Company Information
- 12.4.2 ISPE Business Overview
- 12.4.3 ISPE Revenue in Pharmaceutical Decommissioning Service Business (2021-2026)
- 12.4.4 ISPE Pharmaceutical Decommissioning Service Product Portfolio
- 12.4.5 ISPE Recent Developments
- 12.5 Brilliant Equipment Services
- 12.5.1 Brilliant Equipment Services Company Information
- 12.5.2 Brilliant Equipment Services Business Overview
- 12.5.3 Brilliant Equipment Services Revenue in Pharmaceutical Decommissioning Service Business (2021-2026)
- 12.5.4 Brilliant Equipment Services Pharmaceutical Decommissioning Service Product Portfolio
- 12.5.5 Brilliant Equipment Services Recent Developments
- 12.6 Qualitech Environmental Services
- 12.6.1 Qualitech Environmental Services Company Information
- 12.6.2 Qualitech Environmental Services Business Overview
- 12.6.3 Qualitech Environmental Services Revenue in Pharmaceutical Decommissioning Service Business (2021-2026)
- 12.6.4 Qualitech Environmental Services Pharmaceutical Decommissioning Service Product Portfolio
- 12.6.5 Qualitech Environmental Services Recent Developments
- 12.7 Hughes & Salvidge
- 12.7.1 Hughes & Salvidge Company Information
- 12.7.2 Hughes & Salvidge Business Overview
- 12.7.3 Hughes & Salvidge Revenue in Pharmaceutical Decommissioning Service Business (2021-2026)
- 12.7.4 Hughes & Salvidge Pharmaceutical Decommissioning Service Product Portfolio
- 12.7.5 Hughes & Salvidge Recent Developments
- 12.8 Divestiture
- 12.8.1 Divestiture Company Information
- 12.8.2 Divestiture Business Overview
- 12.8.3 Divestiture Revenue in Pharmaceutical Decommissioning Service Business (2021-2026)
- 12.8.4 Divestiture Pharmaceutical Decommissioning Service Product Portfolio
- 12.8.5 Divestiture Recent Developments
- 12.9 Pharmagraph
- 12.9.1 Pharmagraph Company Information
- 12.9.2 Pharmagraph Business Overview
- 12.9.3 Pharmagraph Revenue in Pharmaceutical Decommissioning Service Business (2021-2026)
- 12.9.4 Pharmagraph Pharmaceutical Decommissioning Service Product Portfolio
- 12.9.5 Pharmagraph Recent Developments
- 12.10 RVA Group
- 12.10.1 RVA Group Company Information
- 12.10.2 RVA Group Business Overview
- 12.10.3 RVA Group Revenue in Pharmaceutical Decommissioning Service Business (2021-2026)
- 12.10.4 RVA Group Pharmaceutical Decommissioning Service Product Portfolio
- 12.10.5 RVA Group Recent Developments
- 12.11 DSM Demolition
- 12.11.1 DSM Demolition Company Information
- 12.11.2 DSM Demolition Business Overview
- 12.11.3 DSM Demolition Revenue in Pharmaceutical Decommissioning Service Business (2021-2026)
- 12.11.4 DSM Demolition Pharmaceutical Decommissioning Service Product Portfolio
- 12.11.5 DSM Demolition Recent Developments
- 12.12 KERAMIDA Inc
- 12.12.1 KERAMIDA Inc Company Information
- 12.12.2 KERAMIDA Inc Business Overview
- 12.12.3 KERAMIDA Inc Revenue in Pharmaceutical Decommissioning Service Business (2021-2026)
- 12.12.4 KERAMIDA Inc Pharmaceutical Decommissioning Service Product Portfolio
- 12.12.5 KERAMIDA Inc Recent Developments
- 12.13 Downwell Enabling Solutions
- 12.13.1 Downwell Enabling Solutions Company Information
- 12.13.2 Downwell Enabling Solutions Business Overview
- 12.13.3 Downwell Enabling Solutions Revenue in Pharmaceutical Decommissioning Service Business (2021-2026)
- 12.13.4 Downwell Enabling Solutions Pharmaceutical Decommissioning Service Product Portfolio
- 12.13.5 Downwell Enabling Solutions Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst